Search Tag: Artificial Intelligence

Executive Health Management

Reimagining Healthcare: A Story of Growth, Innovation and Transformation

2020 09 Mar

With ageing populations on the rise and healthcare funding increasingly strained, the capability to enhance patient experience and improve clinical outcomes while also driving efficiencies will make the difference in the healthcare battleground. According to the latest data provided by the World Economic Forum, the global population will rise from... Read more

Executive Health Management

Hotspot: AI and Ethics in Health Innovation

2020 09 Mar

Summary: AI holds great promise, yet also raises many ethical questions. The field of health and care has much to contribute to and a huge interest in the related technology, governance and regulatory debates. Artificial Intelligence (AI) was certainly a hotspot of attention last year. It is likely to continue to attract much attention this... Read more

Executive Health Management

Facing Digitalisation Head On

2020 09 Mar

Summary: Healthcare digitalisation looks good on paper but putting it into practice is complex, challenging personnel, different departments, modalities and education, to name a few factors impacting implementation. HealthManagement.org spoke to two leading lights on how they think healthcare chiefs need to adapt, to successfully embrace the paradigm... Read more

Executive Health Management

Artificial Intelligence - Putting Patients First

2020 09 Mar

A recent MIT Technology Review Insights survey looked at the current and potential future applications of artificial intelligence (AI) in the healthcare environment. This article discusses the survey’s findings, and looks at how these technologies are ‘re-humanizing’ healthcare, by aiding the transition from target- to value-based care models.... Read more

IMAGING Management

ICH Diagnosis: Could AI Step In Where Radiologists Fail?

2020 26 Feb

  The heavy workload radiologists deal with means that the potential for errors may increase. Misdiagnosis of intracranial haemorrhage (ICH) can lead to an adverse impact on patient outcomes.   You might also like: AI and Radiology: Not Ready For Prime Time   Researchers at Yale School of Medicine have released a... Read more

IT Management

£27mln for Supercomputing Services Drive Scientific Breakthroughs in UK

2020 26 Feb

More scientific breakthroughs from UK researchers, notably in the fields of artificial intelligence (AI) and drug design, can be expected with the launch of state-of-the-art supercomputing services.   The "Seven High Performance Computing (HPC)" services will be supported by a £27 million investment from the Engineering and Physical Sciences... Read more

IT Management

AI and Pharma: What's Ahead?

2020 24 Feb

Precision medicine, also called personalised medicine, makes use of genomics as well as data about the patient's lifestyle and environment, to develop targeted therapies.    The precision medicine market has shown rapid growth in recent years – by more than 10% annually – thanks in large part to advances in bioinformatics. Medical experts... Read more

Cardiology Management

The Impact of Digital Technology on Healthcare

2020 20 Feb

Digital technology has become an integral part of healthcare and is all set to revolutionise the practice of medicine. Digital technology has greatly improved operational efficiency with respect to standards of medical care. The transformation has significantly enhanced the overall experience of both healthcare professionals and patients. Some... Read more

IMAGING Management

Planmed To Present A Broad Range Of Digital Innovations At ECR 2020

2020 20 Feb

The European Congress of Radiology (ECR) is the annual meeting of the European Society of Radiology, where professionals within the field come to meet and discuss all the latest developments in the radiological community. The theme of ECR 2020, “A Clear Vision for Radiology”, represents everything radiologists, radiographers, medical physicists,... Read more

IT Management

First AI-Created Drug Trial

2020 14 Feb

  For the first time, an AI-made drug has reached the clinical trials stage.   Called DSP-1181, the pharmaceutical drug created by AI technology to treat obsessive-compulsive disorder, is in phase 1 trials in Japan.   You might also like: EIT Awards €6 mln to Health Start-ups   The drug is a result of UK-based Exscientia.... Read more